Why the study?
Anesthetic induction in severe pulmonary hypertension risks cardiovascular collapse, and the use of ketamine remains controversial with conflicting recommendations.
Does intravenous ketamine as a co-induction anesthetic agent maintain hemodynamic stability in adult patients with severe pulmonary hypertension undergoing pulmonary thromboendarterectomy?
Does intravenous ketamine as a co-induction anesthetic agent maintain hemodynamic stability in adult patients with severe pulmonary hypertension undergoing pulmonary thromboendarterectomy?
Intravenous ketamine at doses less than 1 mg/kg can be used safely as a co-induction anesthetic agent without causing cardiovascular collapse in adult patients with severe pulmonary hypertension undergoing pulmonary thromboendarterectomy.
Answers are grounded in this paper and cite their sources.
May support ketamine for induction in CTEPH; hypothesis-generating, needs prospective confirmation.
Pulmonary thromboendarterectomy (PTE) surgery is the treatment of choice for patients with chronic thromboembolic pulmonary hypertension (CTEPH). The induction of anesthesia in patients with severe pulmonary hypertension (PHT) can be challenging, with a risk of cardiovascular collapse. The administration of ketamine in patients with PHT is controversial, with some recommendations contraindicating its use. However, ketamine has been used safely in children with severe PHT. We present a retrospective case series of adult patients with severe PHT presenting for PTE surgery, using intravenous ketamine as a co-induction anesthetic agent.
No takes yet. Share an insight, caveat, or question.
Salaunkey et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: